Zenas BioPharma, Inc. (ZBIO)

NASDAQ: ZBIO · Real-Time Price · USD

39.29

-0.92 (-2.29%)

Dec 12, 2025, 12:18 PM EST - Market open

Zenas BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	2,109	342	-	-
Enterprise Value	1,877	-44	-	-
Last Close Price	40.21	8.19	-	-
PS Ratio	112.43	68.45	-	-
PB Ratio	8.64	1.10	-	-
P/TBV Ratio	11.03	1.10	-	-
Debt / Equity Ratio	0.00	0.00	0.87	0.03
Asset Turnover	0.04	0.02	0.70	-
Quick Ratio	5.57	6.12	2.44	2.59
Current Ratio	5.66	6.21	2.57	2.64
Return on Equity (ROE)	-68.33%	-93.22%	-102.89%	-
Return on Assets (ROA)	-33.72%	-46.76%	-23.77%	-
Return on Capital (ROIC)	-43.91%	-57.07%	-35.79%	-
Return on Capital Employed (ROCE)	-72.60%	-52.40%	-60.40%	-154.70%
Earnings Yield	-8.76%	-45.87%	-	-
FCF Yield	-7.32%	-35.00%	-	-
Buyback Yield / Dilution	-1252.33%	-762.01%	-2.61%	-

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q